Evolent Health (NYSE:EVH) is a technology‐enabled services company focused on transforming healthcare delivery through value-based care. Founded in 2011 as a business unit of The Advisory Board Company and spun off via IPO in 2018, Evolent partners with health systems and payers to help them assume risk and improve clinical outcomes while controlling costs. The company is headquartered in Arlington, Virginia and employs a multidisciplinary team of clinicians, technologists and operations experts.
At its core, Evolent Health supports clients in designing, launching and managing value-based care models across Medicare Advantage, Medicaid and commercial segments. Evolent helps organizations transition from fee-for-service to population-based reimbursement by providing care management programs, clinical protocols and actuarial guidance. Its framework enables payers and provider groups to coordinate care, engage patients and drive quality improvements.
Evolent’s suite of solutions encompasses technology platforms and consulting services. The company’s Evolent Risk Manager leverages data analytics to forecast and manage financial performance under risk contracts. Its Care Manager application supports outreach and utilization management, while the Coding Manager drives compliance and accurate risk adjustment. Evolent also offers advanced analytics, regulatory support and performance-benchmarking tools designed to optimize both clinical and financial outcomes.
Serving clients across the United States, Evolent Health works with more than 40 payer and provider organizations in both urban and rural markets. The leadership team is led by President and Chief Executive Officer Frank Williams, who brings decades of experience in managed care innovation, and Chief Financial Officer John Obermeyer, who oversees the company’s financial strategy. Together, they guide Evolent’s mission to improve population health and lower healthcare costs through sustainable value-based partnerships.
AI Generated. May Contain Errors.
